<DOC>
	<DOCNO>NCT01455649</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy safety use everolimus , onset 3 month treatment calcineurin inhibitor .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy Switching Calcineurin Inhibitor Everolimus After Kidney Transplantation Adults</brief_title>
	<detailed_description>The patient meet inclusion exclusion criterion include study randomize two group third month post transplant , use tacrolimus , corticosteroid Mycophenolate sodium . The group 1 undergo conversion calcineurin inhibitor Everolimus within 1 day ( overnight ) , group 2 maintain initial immunosuppression . We start Everolimus 1 mg 2x/day three day begin adjust dose serum level , keep 6 10ng/dL . The dos corticosteroids Mycophenolate sodium retain . There performed renal biopsy randomization 12 month . The glomerular filtration rate calculate monthly use MDRD .</detailed_description>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Patients age 18 65 year old First transplantation recipient PRA &lt; 30 % Living cadaveric donor Stable renal function Patients pregnant breastfeeding , pregnancy define woman status conception gestation conclusion , positive beta hCG test ( &gt; 5mUI/mL ) Provided write informed consent form Cadaveric donor expand criterion Multiple organs transplantation Kidney cold ischemia time &gt; 24 hour Severe rejection episode Banf &gt; IIA Glomerular filtration rate &lt; 35mL/min Presence hard treat dyslipidemia severe hypercholesterolemia ( &gt; 350mg/dL ) hypertriglyceridemia ( &gt; 500mg/dL ) Proteinuria &gt; 800mg/24h Patients history malignancy organic system , treat , within 5 year , without evidence local recurrence metastasis , localize basal cell carcinoma Female childbearing potential without use reliable contraceptive method .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Kidney</keyword>
	<keyword>Transplant</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Everolimus</keyword>
	<keyword>Graft function</keyword>
</DOC>